Analysis of BRCA1 and BRCA2 Variants in Moroccan Patients with Triple-Negative Breast Cancer (TNBC)
Authors:
- 10 June 2025
- book chapter
- Published by Springer Nature
- p. 317-329
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Rare germline genetic variants and risk of aggressive prostate cancerInternational Journal of Cancer, 2020
- Rare Germline Pathogenic Mutations of DNA Repair Genes Are Most Strongly Associated with Grade Group 5 Prostate CancerEuropean Urology Oncology, 2020
- Triple negative breast cancer: A thorough review of biomarkersCritical Reviews in Oncology/Hematology, 2020
- Germline variation in BRCA1/2 is highly ethnic‐specific: Evidence from over 30,000 Chinese hereditary breast and ovarian cancer patientsInternational Journal of Cancer, 2019
- Germline pathogenic variants identified in women with ovarian tumorsGynecologic Oncology, 2018
- Mutational spectrum in a worldwide study of 29,700 families withBRCA1orBRCA2mutationsHuman Mutation, 2018
- Genetic ancestry of a Moroccan population as inferred from autosomal STRsMeta Gene, 2014
- LOVD v.2.0: the next generation in gene variant databasesHuman Mutation, 2011
- Ten novelBRCA1 andBRCA2 mutations in breast and/or ovarian cancer families from northern GermanyHuman Mutation, 2000
- Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten familiesNature Genetics, 1994